Minireviews
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Sep 27, 2023; 15(9): 1879-1891
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.1879
Table 3 Outcomes data from observational studies on abdominal compartment syndrome with acute pancreatitis
Ref.
IAP (mmHg), mean ± SD (range)
Organ dysfunction
Surgical decompression, including type of surgery
Time to intervention from hospitalization, diagnosis of ACS
Outcome
Post-decompressions complications
Pre-surgery
Post-surgery
Husu et al[22], 2021OA: 24 ± 4. CG: 21 ± 5NASOFA: OA: 13 (11-14); CG: 12 (10-15). APACHE II: OA: 23 (17-29); CG: 18 (15-26)ML in OA: 47/47 (100%)60 (36-175) h, NA90 d. mortality: OA: 19/40 (48%); CG: 3/21 (14%)
Smit et al[12], 201627 ± 318 ± 413/13 (100%). AKI: 100%. Respiratory failure: 100%. Shock: 100%10 (76.9%). ML: 3 (33%). Subcostal full-thickness laparostomy: 7 (67%)13.4 ± 6.5 d, 12 (2-176) hMortality: 7 (53.8%). LOS ICU: 48 d. GI ischemia: 61.5%Bowel perforation or fistula: 46.2%
Peng et al[11], 2016PCD: 31 (20-44). ML: 34 (20-51)PCD: 19 (3-40). ML: 15 (2-24)SOFA: PCD-11(2-23), ML-10 (3-24), decreased to 9 (2-24) and 9 (3-24)ML: 61/273 (22.3%). PCD: 212/273 (77.7%)PCD: 61 (2-101) h. ML: 64 (5-95) hMortality: PCD: 40 (19%); ML: 32 (52%). LOS hospital: 125 (21-627) d. LOS ICU: PCD: 14 d, ML: 21 d. Subsequent necrosectomy in PCD: 160 (75%), ML: 49 (80%)Hepatic/portal/superior mesenteric vein/splanchnic vein thrombosis: ML: 3.2%, PCD: 0.9%. Bleeding: ML: 11.4%, PCD: 3.8%. Fistula: ML: 24.6%, PCD:18.4%
Davis et al[14], 201329.5NAAKI: 5 (31.3%). Respiratory failure: 11 (68.8%)16 (35.6%). ML: 100%NA, 3.1 hMortality: 4 (25%). LOS hospital: 146 dFistula: 62.5%. Wound infection: 62.5%. Incisional Hernia: 50%
Boone et al[15], 201342NAMean APACHE: 23.3. Mean ranson: 912 (100%). ML: 12 (100%)< 7 d in 9 patients, NAMortality: 6 (50%). Among survivors: LOS ICU: 37 ± 13 d; LOS hospital: 40.5 ± 25.2 d; IMV: 28 ± 11.4 dInfection: 16%. Fistula: 16%
Leppäniemi et al[16], 201131 (23-45)11 (1-20)Mean SOFA: 12 (14-17)Subcutaneous linea alba fasciotomy: 10 (100%). Subsequently, four required completion laparostomy1-17 d (in 6 cases: < 48 h), NAMortality: 4 (40%). LOS hospital: 35 d; LOS ICU: 26 dHernia: 30%. Bleeding: 20%. Wound infection: 10%. Fistula: 10%
Deng et al[17], 201129 (23-38)7.5 (6-18)Resp failure: 8 (100%). AKI: 7 (87.5%). Hepatic: 7 (87.5%). Shock- 8 (100%)8 (100%). ML plus continuous regional arterial infusion with protease inhibitors and antibiotics via a drug delivery system3-9 d, NAMortality: 1(12.5%), LOS-ICU: 41 d, LOS-hospital- 117 dNot mentioned
Mentula et al[18], 201031.5 (27-35)NAResp failure: 24 (92%). AKI: 14 (54%). Shock: 23 (88%). Liver: 2 (8%)26 (100%). ML: 18 (69.2%). Bilateral subcostal laparostomy: 1 (3.8%). SLAF: 7, 2/7 finally laparostomy1 (0-29) d, NAMortality: 12/26 (46.2%)Intrabdominal infection: 73%. Fistula: 19%
Chen et al[19], 200836.7 ± 5.318.3 ± 3.3MODS: 18 (90%). Shock: 14 (70%)8 (65%). PCD: 5 (25%). ML: 5 (25%). Combined: 3 (15%)NA, 28.38 ± 2.29 hMortality: 15/20 (75%)No complications reported
De Waele et al[20], 2005> 25NAResp failure: 20 (98%). AKI: 18 (86%). Shock: 19 (94%)ML: 4/21. Indication for surgery: ACS: 4 (44.4%)3, < 24 hMortality: 3/4 (75%). LOS ICU: 21 (10-37) d. LOS hospital: 42 (20-90) d. IMV: 15 (12.6) dNo complications reported
Tao et al[21], 2003> 20NAResp. failure: 100%. Shock: 100%18/23 (78.2%). ML with drainage: 100%NA, 5-22 hMortality: 3/18 (16.7%). Definitive closures 3-5 dHemorrhage: 42%. Abscess: 19.2%. Perforation/fistula: 3.8%